May 20, 2025
Novo Holdings Boston office receives second consecutive Best Place to Work award from the Boston Business Journal
May 15, 2025
Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities
Apr 24, 2025
Novo Holdings and EIFO invest EUR48 million in HealthCap IX to strengthen the Nordic life sciences ecosystem
Apr 02, 2025
Novo Holdings posts record Total Income and Investment Returns of DKK 60 billion (EUR8.0 billion) in 2024, with the Investment Portfolio delivering above-benchmark returns, alongside strong growth at the Novo Group companies
Mar 26, 2025
Novo Holdings participates in EUR23 million Series A for Tribune Therapeutics to advance next-generation anti-fibrotic therapies
Mar 03, 2025
Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Jan 06, 2025
Novo Holdings Participates in EUR90 Million Series A Financing Round for Orbis Medicines to Support Development of Oral Macrocycle Drugs
Dec 23, 2024
European Energy and Novo Holdings announce joint venture to triple renewable energy capacity of German onshore wind parks
Nov 12, 2024
Novo Holdings co-leads $181.4 million Series D financing in Alentis Therapeutics to advance groundbreaking antibody-drug conjugates (ADCs) for solid tumours
Oct 10, 2024
Novo Holdings Launches Portfolio Company Booster Therapeutics to Advance New Class of Small Molecule Proteasome Activator Therapeutics
Aug 01, 2024
Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies
Jul 18, 2024
Novo Holdings Portfolio Company Invetx to be Acquired by Dechra Pharmaceuticals
Jul 16, 2024
Novo Holdings leads $100 million Series C financing of Asceneuron to advance groundbreaking therapy for Alzheimer's disease
Jul 08, 2024
Novo Holdings co-leads £90 million ($114 million) Series A financing for Myricx Bio to advance a novel payload class for antibody-drug conjugates
May 15, 2024
Novo Holdings to acquire majority stake in Single Use Support
May 01, 2024
Novo Holdings commits DKK 1.4 billion (EUR188 million) to build a quantum technology start-up ecosystem
Apr 03, 2024
2023 Novo Holdings Asia Investments Annual Review/Business Update
Mar 15, 2024
2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Mar 14, 2024
Novo Holdings Joins EUR30M Series A Financing for Asgard Therapeutics, Leader In In Vivo Cell Reprogramming To Treat Cancer
Feb 06, 2024
Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India